ATTUNE® knee system four-year revision rate is lower than total knee class
DePuy Synthes announced in June the new ATTUNE® Knee implant survivorship data based on an Implant Summary Report obtained from...
Read MoreBONESUPPORT™ appoints Michael Diefenbeck as Chief Medical Officer
BONESUPPORT, a manufacturer of injectable bioceramic bone scaffolds to treat bone voids caused by trauma, infection, disease or relatedsurgery, has announced...
Read MoreReport demonstrates clinical and economic value of the ATTUNE Knee system
DePuy Synthes recently released the report, “Improving the Value of Primary Total Knee Arthroplasty: the ATTUNE® Knee System,” that analyses...
Read MoreSafe Orthopaedics offers new technologies to treat traumatic injuries caused due to osteoperosis or bone metastases
Safe Orthopaedics has produced a transverse connector designed to rigidify the stabilisation of posterior spinal osteosynthesis, as well as cement...
Read MoreCorin and Simpleware develop personalised hip replacements
The Exeter-based Simpleware product group, part of Synopsys, is helping the Corin Group achieve breakthroughs in personalising total hip replacement (THR)....
Read MoreTrump wants to double device user fees for manufacturers
President Trump wants the medical device and pharmaceutical industries to pay the full cost to push devices and drugs through...
Read MoreVisit orthopaedic virtual tradeshow
Following the success of the first edition in 2013, SYNTHES’ 3D is pleased to announce the launch of the new...
Read MoreBONESUPPORT™ founder Lars Lidgren receives the 2017 OREF Clinical Research Kappa Delta Award
BONESUPPORT, a company producing innovative injectable bioceramic bone scaffolds to treat bone voids caused by trauma, infection, disease or related surgery, have...
Read More